Insulin Degludec (U-100) Vials and Loteprednol and Tobramycin
Determining the interaction of Insulin Degludec (U-100) Vials and Loteprednol and Tobramycin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: loteprednol / tobramycin ophthalmic
Brand name: Zylet
Synonyms: Loteprednol and tobramycin (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Degludec (U-100) Vials-Loteprednol and tobramycin ophthalmic
- Insulin Degludec (U-100) Vials-Loteprednol Etabonate
- Insulin Degludec (U-100) Vials-Loteprednol Eye Drops
- Insulin Degludec (U-100) Vials-Loteprednol Eye Drops 0.2%
- Insulin Degludec (U-100) Vials-Loteprednol Eye Drops 0.5% and 1%
- Insulin Degludec (U-100) Vials-Loteprednol Eye Gel
- Loteprednol and Tobramycin-Insulin Degludec (U-200) Prefilled Pens
- Loteprednol and Tobramycin-Insulin degludec and liraglutide
- Loteprednol and Tobramycin-Insulin degludec and liraglutide Subcutaneous
- Loteprednol and Tobramycin-Insulin degludec Subcutaneous
- Loteprednol and Tobramycin-Insulin detemir
- Loteprednol and Tobramycin-Insulin Detemir (Cartridges and Prefilled Syringes)